Top Industry News

Eli Lilly and Company has announced an investment of $3.5 billion in a new manufacturing facility in Pennsylvania. The expansion is part of the company’s multi-year $50-billion investments in US capital expansion…

The US Food and Drug Administration (FDA) has announced that it is accepting requests to participate in the FDA PreCheck pilot program, a new program the agency says is designed to…

The Indian government has announced the launch of Biopharma Shakti, a national initiative with an investment of $1.1 billion over five years, aimed at strengthening India’s end-to-end ecosystem for biologics and biosimilars.  …

The latest from CDMOs, CMOs, and suppliers featuring Piramal Pharma Solutions, Nanologia/Ardena, Cellares/Stanford and Mabtech/Sai Life Sciences.   Chemicals/Chemical API Manufacturing * Nanologica Acquires API Mfg Facility from Ardena Formulation Development/Drug Product Manufacturing * Piramal Pharma Solutions Introduces…

A roundup of news from the large and mid-sized bio/pharmaceutical companies featuring AstraZeneca, Roche, Takeda, and SK bioscience. Highlights below.   For the latest news roundup on small and Emerging Pharma companies, see Biotech Briefs.  Partnering…

The latest from small and Emerging Pharma companies featuring Newsoara, vTv Therapeutics, Angitia Biopharmaceuticals, Biomice, Lishan Biopharmaceuticals and Spruce Biosciences.  For news on the large and mid-sized bio/pharmaceutical companies, see Global…

AstraZeneca has announced a $15-billion investment in China through 2030 to expand medicines manufacturing and research and development (R&D).   China is AstraZeneca’s second-largest market and a strategic hub for global innovation,…

The latest from CDMOs, CMOs, and suppliers featuring Siegfried, Cellares, Alcami, Recipharm, Veranova, iOrganBio and Coating Place.   Chemicals/Chemical API Manufacturing * Siegfried to Acquire Drug-Substance Business of Noramco & Extracas Bioscience Biologics Manufacturing * Cellares Raises…

A roundup of news from the large and mid-sized bio/pharmaceutical companies featuring Eli Lilly and Company, Boehringer Ingelheim, AstraZeneca, and Halozyme. Highlights below.   For the latest news roundup on small and…

The latest from small and Emerging Pharma companies featuring Qilu, Eikon Therapeutics, Insilico, Eclipsebio, Terrain Bio, Elysium Therapeutics, and Fortitude Biosciences.  For news on the large and mid-sized bio/pharmaceutical companies, see…